Active Surveillance Use for Favorable-Risk Prostate Cancer in a Veterans Affairs Population
This Research Letter describes the incidence and quality of active surveillance use for prostate cancer in the national Veterans Affairs Healthcare System.
Authors
- Kenute Myrie
- John Bihn (ORCID: https://orcid.org/0000-0001-8029-8991)
- Jennifer La (ORCID: https://orcid.org/0000-0003-2266-0221)
- Matthew R. Cooperberg (ORCID: https://orcid.org/0000-0003-4339-6685)
- V. Nhan
- Channing J. Paller
- Grace Lee
- PROFOUND-VET Investigators
- Nathanael R. Fillmore
- John M. Culnan
Institutions
- Boston University (US)
- San Francisco VA Medical Center (US)
- United States Department of Veterans Affairs (US)
- Harvard University (US)
- Johns Hopkins University (US)
- University of California, San Francisco (US)
- VA Boston Healthcare System (US)
- Department of Veterans Affairs (AU)
- Sidney Kimmel Comprehensive Cancer Center (US)
- UCSF Helen Diller Family Comprehensive Cancer Center (US)
Publication Details
- Journal
- JAMA
- Published
- 2026-08-13
- DOI
- https://doi.org/10.1001/jama.2026.13471
- Primary Topic
- Prostate Cancer Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00